{"ORPHApacket":[{"ORPHApacketID":"97253","date":"2019-12-05 20:21:07","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"97253","Name":[{"lang":"en","label":"Neuroendocrine tumor of pancreas"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_97253","DisorderType":[{"Name":[{"lang":"en","label":"Category"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_557495"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Neuroendocrine neoplasm of pancreas"}],"ORPHA":"506052","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_506052"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Pancreatic endocrine tumor, also known as pancreatic neuroendocrine tumor (PNET), describes a group of endocrine tumors originating in the pancreas that are usually indolent and benign, but may have the potential to be malignant. They can be functional, exhibiting a hormonal hypersecretion syndrome, but can be non-functional presenting with non-specific symptoms and include insulinoma, glucagonoma, VIPoma, somatostatinoma (SSoma), PPoma and Zollinger-Ellison syndrome (ZES, or gastrinoma) and other ectopic hormone producing tumors (such as GRFoma) (see these terms)."}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Adult"}]}]}],"TypeOfInheritanceList":[{"count":"2","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal dominant"}]},{"Name":[{"lang":"en","label":"Not applicable"}]}]}],"SynonymList":[{"count":"7","Synonym":[{"lang":"en","label":"PNET"},{"lang":"en","label":"Pancreatic NET"},{"lang":"en","label":"Pancreatic neuroendocrine tumor"},{"lang":"en","label":"Well-differentiated NEN of pancreas"},{"lang":"en","label":"Well-differentiated neuroendocrine neoplasm of pancreas"},{"lang":"en","label":"Well-differentiated pancreatic NEN"},{"lang":"en","label":"Well-differentiated pancreatic neuroendocrine neoplasm"}]}]}]}